The role of the renin-angiotensin system in the pathogenesis of preeclampsia - New insights into the renin-angiotensin system in preeclampsia

Medical Hypotheses

Volumn 82, Issue 3, 2014, Pages 362-367

  Seki, H ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; RENIN-ANGIOTENSIN SYSTEM;

EID: 84893927764     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.12.024     Document Type: Article

References (73)

1. Sibai B.M., Dekker G., Kupferminc M. Pre-eclampsia. Lancet 2005, 365:785-799.
2. Kajantie E., Eriksson J.G., Osmond C., Thornburg K., Barker D.I. Pre-eclampsia is associated with increased with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke 2009, 40:1176-1180.
3. Bauer S.T., Cleary K.L. Cardiopulmonary complications of pre-eclampsia. Semin Perinatol 2009, 33:158-165.
4. Zeeman G.G. Neurologic complications of pre-eclampsia. Semin Perinatol 2009, 33:166-172.
5. Vatten L.J., Skaerven R. Is pre-eclampsia more than one disease?. BJOG 2004, 111:298-302.
6. Satoh K., Seki H., Sakamoto H. Role of prostaglandins in pregnancy-induced hypertension. Am J Kidney Dis 1991, 17:133-138.
7. Rolfo A., Many A., Racano A., et al. Abnormalities in oxygen sensing define early and late onset preeclampsia as distinct pathologies. PLoS One 2010, 5:e13288.
8. Stettler R.W., Cunningham F.G. Natural history of chronic proteinuria complicating pregnancy. Am J Obstet Gynecol 1992, 167:1219-1224.
9. Roberts J.M. Preeclampsia: what we know and what we do not know. Semin Perinatol 2000, 24:24-28.
10. Karamanchi S.A., Bdolah Y. Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question. Endocrinology 2004, 145:4835-4837.
11. Wang A., Rana S., Karumanchi S.A. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology 2009, 24:147-158.
12. Maynaud S.E., Min J.Y., Merchan J., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003, 111:649-658.
13. Levine R.J., Lam C., Qian C., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006, 355:992-1005.
14. Rana S., Karumanchi S.A., Levine R.J., et al. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension 2007, 50:137-142.
15. Santos P.C.J.L., Krieger J.E., Pereira A.C. Renin-angiotensin system, hypertension, and chronic kidney disease: pharmacogenic implications. J Pharmacol Sci 2012, 120:77-88.
16. Gant N.F., Daley G.L., Chand S., Whalley P.J., MacDonald P.C. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973, 52:2682-2689.
17. Weir R.J., Paintin D.B., Brown J.J., et al. A serial study in pregnancy of the plasma concentrations of renin, corticosteroids, electrolytes and proteins and of haematocrit and plasma volume. J Obstet Gynaecol Br Commonw 1971, 78:590-602.
18. Brown J.J., Davies D.L., Lever A.F., Robertson J.I. Plasma renin concentration in human hypertension. II. Renin in relation to aetiology. Br Med J 1965, 2:1215-1219.
19. Brown J.J., Davies D.L., Doak P.B., Lever A.F., Robertson J.I., Trust P. Plasma renin concentration in the hypertensive diseases of pregnancy. J Obstet Gynaecol Br Commonw 1966, 73:410-417.
20. Wallukat G., Homuth V., Fischer T., et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 1999, 103:945-952.
21. Zhou C.C., Ahmad S., Mi T., et al. Autoantibody from women with preeclampsia induced soluble fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling. Hypertension 2008, 51:1010-1019.
22. Bobst S.M., Day M.C., Gilstrap L.C., Xia Y., Kellems R.E. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion. Am J Hypertens 2005, 18:330-336.
23. Packham D.K., Mathews D.C., Fairley K.F., Whitworth J.A., Kincaid-Smith P.S. Morphometric analysis of pre-eclampsia in women biopsied in pregnancy and post-partum. Kidney Int 1988, 34:704-711.
24. Xu Y., Berrou J., Chen X., et al. Induction of urokinase receptor expression in nephrotoxic nephritis. Exp Nephrol 2001, 9:397-404.
25. Dechend R., Viedt C., Muller D.N., et al. AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation 2003, 107:1632-1639.
26. Burton G.J., Hempstock J., Jauniaux E. Oxygen, early embryonic metabolism and free radical-mediated embryopathies. Reprod Biomed Online 2003, 6:84-96.
27. Dechend R., Homuth V., Wallukat G., et al. AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation 2000, 101:2382-2387.
28. Irani R.A., Xia Y. The functional role of the rennin-angiotensin system in pregnancy and preeclampsia. Placenta 2008, 29:763-771.
29. Pijnenborg R., Dixon G., Robertson W.B., Brosens I. Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta 1980, 1:3-19.
30. Pijnenborg R., Anthony J., Davey D.A., et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991, 98:648-655.
31. Hanna J., Goldman-Wohl D., Hamani Y., et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 2006, 12:1065-1074.
32. Aluvihare V.R., Kallikourdis M., Betz A.G. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004, 5:266-271.
33. 25+ T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biol Reprod 2009, 80:1036-1045.
34. Nagamatsu T., Fujii T., Kusumi M., et al. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 2004, 145:4838-4845.
35. Khaliq A., Dunk C., Jiang J., et al. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hypoxia" in intrauterine growth restriction. Lab Invest 1999, 79:151-170.
36. Tsatsaris V., Goffin F., Munaut C., et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab 2003, 88:5555-5563.
37. Lash G.E., Taylor C.M., Trew A.J., et al. Vascular endothelial growth factor and placental growth factor release in cultured trophoblast cells under different oxygen tensions. Growth Factors 2002, 20:189-196.
38. Morgan T., Craven C., Ward K. Human spiral artery renin-angiotensin system. Hypertension 1998, 32:683-687.
39. Pringle K.G., Tadros M.A., Callister R.J., Lumbers E.R. The expression and localization of the human placental prorenin/renin-angiotensin system throughout pregnancy: roles in trophoblast invasion and angiogenesis?. Placenta 2011, 32:956-962.
40. Herr D., Rodewald M., Fraser H.M., Hack G., Konrad R., Kreienberg R., et al. Regulation of endothelial proliferation by the renin-angiotensin system in human umbilical vein endothelial cells. Reproduction 2008, 136:125-130.
41. Sowers J.R., Zemel M.B., Bronsteen R.A., et al. Erythrocyte cation metabolism in preeclampsia. Am J Obstet Gynecol 1989, 161:441-445.
42. 2+ mobilization through angiotensin receptor activation. Circulation 2004, 110:1612-1619.
43. Li X., Shams M., Zhu J., et al. Cellular localization of AT1 receptor mRNA and protein in normal placenta and its reduced expression in intrauterine growth restriction. Angiotensin II stimulates the release of vasorelaxants. J Clin Invest 1998, 101:442-454.
44. Shaw K.J., Do Y.S., Kjos S., et al. Human deciduas is a major source of rennin. J Clin Invest 1989, 83:2085-2092.
45. Anton L., Merill D.C., Neves L.A.A., et al. The uterine placental bed renin-angiotensin system in normal and preeclamptic pregnancy. Endocrinology 2009, 150:4316-4325.
46. Herse F., Dechend R., Harsem N.K., et al. Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia. Hypertension 2007, 49:604-611.
47. Abdalla S., Lother H., el Massiery V., Quitterer U. Increased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med 2001, 7:1003-1009.
48. Bellamy L., Casas J.P., Hingorani A.D., Williams D.J. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007, 335:974-977.
49. Hubel C.A., Wallukat G., Wolf M., et al. Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension 2007, 49:612-617.
50. Nguyen G., Delarue F., Burcklé C., Bouzhir L., Giller T., Sraer J.D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002, 109:1417-1427.
51. Ichihara A., Hayashi M., Kaneshiro Y., et al. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin. J Clin Invest 2004, 114:1128-1135.
52. Ichihara A., Kaneshiro Y., Takemitsu T., et al. Contribution of nonproteolytically activated prorenin in glomeruli to hypertensive renal damage. J Am Soc Nephrol 2006, 17:2495-2503.
53. Ichihara A., Kaneshiro Y., Takemitsu T., et al. Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension 2006, 47:894-900.
54. Ichihara A., Suzuki F., Nakagawa T., et al. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol 2006, 17:1950-1961.
55. Ringholm L., Pedersen-Bjergaard U., Thorsteinsson B., Boomsma F., Damm P., Mathiesen E.R. A high concentration of prorenin in early pregnancy is associated with development of pre-eclampsia in women with type 1 diabetes. Diabetologia 2011, 54:1615-1619.
56. Lenz T. Prorenin and active renin in human fetal circulation. Acta Obstet Gynecol Scand 1996, 75:291-293.
57. Singh H.J., Rahman A., Larmie E.T., Nila A. Raised prorenin and renin concentrations in pre-eclamptic placentae when measured after acid activation. Placenta 2004, 25:631-636.
58. Skinner S.L., Lumbers E.R., Symonds E.H. Renin concentrations in human fetal and maternal tissues. Am J Obstet Gynecol 1968, 101:529-533.
59. Fernandez L.A., Tarlatzis B.C., Rzasa P.J., et al. Renin-like activity in ovarian follicular fluid. Fertil Steril 1985, 44:219-223.
60. Glorioso N., Atlas S.A., Laragh J.H., Jewelewicz R., Sealey J.E. Prorenin in high concentrations in human ovarian follicular fluid. Science 1986, 233:1422-1424.
61. Derkx F.H., Alberda A.T., Zeilmaker G.H., Schalekamp M.A. High concentrations of immunoreactive renin, prorenin and enzymatically-active renin in human ovarian follicular fluid. Br J Obstet Gynaecol 1987, 94:4-9.
62. Derkx F.H., Alberda A.T., de Jong F.H., Zeilmaker F.H., Makovitz J.W., Schalekamp M.A. Source of plasma prorenin in early and late pregnancy: observations in a patient with primary ovarian failure. J Clin Endocrinol Metab 1987, 65:349-354.
63. Lumbers E.R. Activation of renin in amniotic fluid by low pH. Enzymologia 1971, 40:329-336.
64. Poisner A.M., Wood G.W., Poisner R., Inagami T. Localization of renin in trophoblasts in human chorion laeve at term pregnancy. Endocrinology 1981, 109:1150-1155.
65. Sealey J.E., von Lutterotti N., Rubattu S., et al. The greater renin system. Its prorenin-directed vasodilator limb. Relevance to diabetes mellitus, pregnancy, and hypertension. Am J Hypertens 1991, 4:972-977.
66. Fernandez L.A., Twickler J., Mead A. Neovascularization produced by angiotensin II. J Lab Clin Med 1985, 105:141-145.
67. Kalenga M.K., Thomas K., de Gasparo M., De Hertogh R. Determination of renin, angiotensin converting enzyme and angiotensin II levels in human placenta, chorion and amnion from women with pregnancy induced hypertension. Clin Endocrinol 1996, 44:429-433.
68. Brar H.S., Kjos S.L., Dougherty W., Do Y.S., Tam H.B., Hsueh W.A. Increased fetoplacental active renin production in pregnancy-induced hypertension. Am J Obstet Gynecol 1987, 157:363-367.
69. Poranen A.K., Aalto M., Matiniauri I., Ekblad U. Total renin in preeclamptic placenta. Hypertens Pregnancy 1996, 15:347-352.
70. Derkx F.H., Schalekamp M.A. Human prorenin: pathophysiology and clinical implications. Clin Exp Hypertens A 1988, 10:1213-1225.
71. Takahashi H., Ichihara A., Kaneshiro Y., et al. Regression of nephropathy developed in diabetes by (Pro)renin receptor blockade. J Am Soc Nephrol 2007, 18:2054-2061.
72. Itskovitz J., Rubattu S., Levron J., Sealey J.E. Highest concentrations of prorenin and human chorionic gonadotropin in gestational sacs during early human pregnancy. J Clin Endocrinol Metab 1992, 75:906-910.
73. Watanabe N., Bokuda K., Fujiwara T., et al. Soluble (pro)renin receptor and blood pressure during pregnancy. A prospective cohort study. Hypertension 2012, 60:1250-1256.